Jia Che
Overview
Explore the profile of Jia Che including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian Y, Lv Y, Wang H, Che J, Cui F, Guo J, et al.
Prenat Diagn
. 2024 Oct;
44(12):1509-1517.
PMID: 39394648
Background: Branchio-oto-renal (BOR) spectrum disorders are linked to pathogenic variants in the EYA1 gene, presenting significant challenges for prenatal ultrasound screening due to their phenotypic variability and complexity. Understanding these...
2.
Liu Q, Che J, Yu Y, Chu D, Zhang H, Zhang F, et al.
Appl Biochem Biotechnol
. 2024 Jun;
196(11):8410-8428.
PMID: 38878161
Chitin is the most productive nitrogen-containing polysaccharide in nature with immense potential for transforming into a range of chemicals. However, its dense crystal structure poses a challenge for depolymerization, limiting...
3.
Li P, Guo J, Che J, Cui F, Lyu Y, Zhang H, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
. 2024 Mar;
41(3):266-270.
PMID: 38448012
Objective: To analyze ultrasonographic manifestations and genetic etiology of nine fetuses with 7q11.23 duplication syndrome. Methods: Ultrasonographic finding, pregnancy outcome and follow-up of nine fetuses detected at the Prenatal Diagnosis...
4.
Guo J, Li P, Che J, Zhai S, Tian W, Li Y, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
. 2024 Feb;
41(2):145-149.
PMID: 38311551
Objective: To explore the pregnancy outcome and postpartum clinical phenotype of LCR22B/C~D central 22q11.2 deletion syndrome. Methods: For fetuses diagnosed with central 22q11.2 deletion by chromosomal microarray analysis (CMA) at...
5.
Zhi Y, Liu L, Cui S, Li Y, Chen X, Che J, et al.
Arch Gynecol Obstet
. 2022 Dec;
308(6):1723-1735.
PMID: 36464758
Objective: To explore pathogenic/likely pathogenic copy number variations (P/LP CNVs) and regions of homozygosity (ROHs) in fetal central nervous system (CNS) malformations. Methods: A cohort of 539 fetuses with CNS...
6.
Zhang R, Zhang G, Li B, Wang J, Wang J, Che J, et al.
Dis Markers
. 2022 Oct;
2022:5378963.
PMID: 36246563
Methods: A tissue microarray (TMA) containing 76 individual colorectal tumor samples and 28 adjacent normal samples was constructed, and the expression levels of LINC01314 and miR-96 were detected by fluorescence...
7.
Yang G, Tan H, Li S, Zhang M, Che J, Li K, et al.
Bioresour Technol
. 2019 Dec;
300:122645.
PMID: 31887580
Citrus wastes disposal is a problem faced by many juice plants due to high disposal costs. However, the citrus peel wastes (CPW) biomass, as bulk bioresources from the agro-industrial waste,...
8.
Huang L, Wen C, Yang X, Lou Q, Wang X, Che J, et al.
Cell Death Dis
. 2018 Feb;
9(3):271.
PMID: 29449544
PEAK1 is upregulated in multiple human malignancies and has been associated with tumor invasion and metastasis, but little is known about the role of PEAK1 in colorectal cancer (CRC) progression....
9.
Che J, Pan L, Yang X, Liu Z, Huang L, Wen C, et al.
Mol Clin Oncol
. 2017 Dec;
7(6):943-952.
PMID: 29285354
In the past decades, various studies have suggested a possible link between thymidine phosphorylase (TP) level and colorectal cancer (CRC) treated with 5-fluorouracil (5-FU)-based chemotherapy; however, they have arrived at...
10.
Wen C, Chen J, Zhang D, Wang H, Che J, Qin Q, et al.
Cancer Lett
. 2016 Oct;
383(2):295-308.
PMID: 27713084
5-fluorouracil (5-FU)-based chemotherapy is the main chemotherapeutic approach for colorectal cancer (CRC) treatment. Because chemoresistance occurs frequently and significantly limits CRC therapies, a novel agent is needed. Pseudolaric acid B...